TABLE 1.
Open restorative proctocolectomy (n = 290) |
Laparoscopic restorative proctocolectomy (n = 100) |
P value | |
---|---|---|---|
Age (y, mean ± SD) | 38.7 ± 13.6 | 37.5 ± 13.7 | NS |
Female (%)/male (%) | 119 (41%)/171 (59%) | 54 (54%)/46 (46%) | 0.03 |
BMI (kg/m2, mean ± SD) | 26.3 ± 5.1 | 24.2 ± 4.4 | <0.001 |
Operative data | |||
ASA score* | 0.01* | ||
1 (%) | 20 (7%) | 2 (2%) | |
2 (%) | 233 (83%) | 91 (95%) | |
3 (%) | 26 (10%) | 3 (3%) | |
Hgb (g/dL, mean ± SD) | 12.8 ± 2.1 | 12.7 ± 2.1 | NS |
Past medical history | |||
COPD/asthma (%) | 16 (6%) | 4 (4%) | NS |
Diabetes (%) | 16 (6%) | 7 (7%) | NS |
HTN (%) | 27 (9%) | 9 (9%) | NS |
CAD (%) | 9 (3%) | 1 (1%) | NS |
Surgical history | |||
Any prior abdominal surgery | 104 (36%) | 24 (24%) | 0.04 |
Prior colectomy (total or subtotal) (%) | 34 (12%) | 2 (2%) | 0.002 |
Prior appendectomy (%) | 8 (3%) | 6 (6%) | NS |
Prior cholecystectomy (%) | 8 (3%) | 6 (6%) | NS |
Any prior gynecological surgery (%) | 34 (12%) | 9 (9%) | NS |
Prior C-section (%) | 20 (7%) | 7 (7%) | NS |
Perioperative medication use | |||
Steroids (%) | 180 (62%) | 60 (60%) | NS |
5-ASA meds (%) | 182 (63%) | 58 (58%) | NS |
Other immunomodulators (%) | 29 (10%) | 10 (10%) | NS |